Loading...
The availability, cost, limitations, learning curve and future of robotic systems in urology and prostate cancer surgery
Chedgy, Edmund
Chedgy, Edmund
Citations
Altmetric:
Affiliation
South Warwickshire University NHS Foundation Trust; Freeman Hospital; Dartford & Gravesham NHS Trust; University Hospital Southampton
Other Contributors
Publication date
2023-03-15
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Robot-assisted surgical systems (RASS) have revolutionised the management of many urological conditions over the last two decades with robot-assisted radical prostatectomy (RARP) now being considered by many to be the preferred surgical approach. Intuitive Surgical has dominated the market during this time period with successive iterations of the da Vinci model. The expiration of patents has opened the RASS market and several new contenders have become available or are currently in development. This comprehensive narrative review aims to explore the merits of each robotic system as well as the evidence and barriers to their use. The newly developed RASS have increased the versality of robotic surgical systems to a wider range of settings through advancement in technology. The increased competition may result in an overall reduction in cost, broadening the accessibility of RASS. Learning curves and training remain a barrier to their use, but the situation appears to be improving through dedicated training programmes. Outcomes for RARP have been well investigated and tend to support improved early functional outcomes. Overall, the rapid developments in the field of robot-assisted surgery indicate the beginning of a promising new era to further enhance urological surgery.
Citation
Hughes T, Rai B, Madaan S, Chedgy E, Somani B. The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery. J Clin Med. 2023 Mar 15;12(6):2268. doi: 10.3390/jcm12062268.
Type
Article